Ulisse Biomed S.p.A. (BIT:UBM)
Italy · Delayed Price · Currency is EUR 1.090
-0.060 (-5.22%)
Oct 10, 2025, 5:18 PM CET
Ulisse Biomed Revenue
In the year 2024, Ulisse Biomed had annual revenue of 767.93K EUR with 1,059.87% growth. Ulisse Biomed had revenue of 397.07K in the half year ending December 31, 2024, with 431.07% growth.
Revenue
767.93K
Revenue Growth
+1,059.87%
P/S Ratio
28.82
Revenue / Employee
51.44K
Employees
22
Market Cap
26.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 767.93K | 701.72K | 1,059.87% |
| Dec 31, 2023 | 66.21K | -72.23K | -52.17% |
| Dec 31, 2022 | 138.44K | -142.00K | -50.64% |
| Dec 31, 2021 | 280.44K | -325.06K | -53.68% |
| Dec 31, 2020 | 605.50K | 594.63K | 5,469.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| DiaSorin | 1.22B |
| Amplifon | 2.41B |
| EL.En. | 579.71M |
| Philogen | 84.66M |
| Safilo Group | 998.89M |
| GPI S.p.A. | 531.42M |
| Pharmanutra | 122.25M |